BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1021 related articles for article (PubMed ID: 26611869)

  • 1. First-trimester screening for trisomies 18 and 13, triploidy and Turner syndrome by detailed early anomaly scan.
    Wagner P; Sonek J; Hoopmann M; Abele H; Kagan KO
    Ultrasound Obstet Gynecol; 2016 Oct; 48(4):446-451. PubMed ID: 26611869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sphenofrontal distance in euploid and aneuploid fetuses.
    Abele H; Sonek J; Goldschmid D; Wagner P; Hoopmann M; Kagan KO
    Ultrasound Obstet Gynecol; 2017 Aug; 50(2):187-191. PubMed ID: 27550089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Value of Detailed First-Trimester Ultrasound Anomaly Scan for the Detection of Chromosomal Abnormalities.
    Tekesin I
    Ultraschall Med; 2019 Dec; 40(6):743-748. PubMed ID: 30241105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First-trimester screening for chromosomal abnormalities by integrated application of nuchal translucency, nasal bone, tricuspid regurgitation and ductus venosus flow combined with maternal serum free β-hCG and PAPP-A: a 5-year prospective study.
    Ghaffari SR; Tahmasebpour AR; Jamal A; Hantoushzadeh S; Eslamian L; Marsoosi V; Fattahi F; Rajaei M; Niroomanesh S; Borna S; Beigi A; Khazardoost S; Saleh-Gargari S; Rahimi-Sharbaf F; Farrokhi B; Bayani N; Tehrani SE; Shahsavan K; Farzan S; Moossavi S; Ramezanzadeh F; Dastan J; Rafati M
    Ultrasound Obstet Gynecol; 2012 May; 39(5):528-34. PubMed ID: 21793085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ductus venosus Doppler in screening for trisomies 21, 18 and 13 and Turner syndrome at 11-13 weeks of gestation.
    Maiz N; Valencia C; Kagan KO; Wright D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2009 May; 33(5):512-7. PubMed ID: 19338027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved diagnostic accuracy by using secondary ultrasound markers in the first-trimester screening for trisomies 21, 18 and 13 and Turner syndrome.
    Karadzov-Orlic N; Egic A; Milovanovic Z; Marinkovic M; Damnjanovic-Pazin B; Lukic R; Joksic I; Curkovic A; Mikovic Z
    Prenat Diagn; 2012 Jul; 32(7):638-43. PubMed ID: 22570267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fetal nasal bone in screening for trisomies 21, 18 and 13 and Turner syndrome at 11-13 weeks of gestation.
    Kagan KO; Cicero S; Staboulidou I; Wright D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2009 Mar; 33(3):259-64. PubMed ID: 19248005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tricuspid regurgitation in screening for trisomies 21, 18 and 13 and Turner syndrome at 11+0 to 13+6 weeks of gestation.
    Kagan KO; Valencia C; Livanos P; Wright D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2009 Jan; 33(1):18-22. PubMed ID: 19031473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Facial markers in second- and third-trimester fetuses with trisomy 18 or 13, triploidy or Turner syndrome.
    Kagan KO; Sonek J; Berg X; Berg C; Mallmann M; Abele H; Hoopmann M; Geipel A
    Ultrasound Obstet Gynecol; 2015 Jul; 46(1):60-5. PubMed ID: 25175793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mixture model of nuchal translucency thickness in screening for chromosomal defects.
    Wright D; Kagan KO; Molina FS; Gazzoni A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Apr; 31(4):376-83. PubMed ID: 18383462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dilated fourth ventricle in fetuses with trisomy 18, trisomy 13 and triploidy at 11-13 weeks' gestation.
    Loureiro T; Ferreira AF; Ushakov F; Montenegro N; Nicolaides KH
    Fetal Diagn Ther; 2012; 32(3):186-9. PubMed ID: 22846426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study on several ultrasound markers combined maternal serum biochemical markers to screen fetal chromosomal aneuploidy at 11 to 13(+)6 weeks of gestation].
    Chen X; Chang Y; Cui HY; Ren CC; Yu BY
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):815-8. PubMed ID: 24444556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of an anatomical origin for altered ductus venosus flow velocity waveforms in first-trimester human fetuses with increased nuchal translucency.
    Burger NB; Matias A; Kok E; de Groot CJ; Christoffels VM; Bekker MN; Haak MC
    Prenat Diagn; 2016 Jun; 36(6):537-44. PubMed ID: 27060369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal serum biochemistry at 11-13(+6) weeks in relation to the presence or absence of the fetal nasal bone on ultrasonography in chromosomally abnormal fetuses: an updated analysis of integrated ultrasound and biochemical screening.
    Cicero S; Spencer K; Avgidou K; Faiola S; Nicolaides KH
    Prenat Diagn; 2005 Nov; 25(11):977-83. PubMed ID: 16245371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fetal head-to-trunk volume ratio in chromosomally abnormal fetuses at 11 + 0 to 13 + 6 weeks of gestation.
    Falcon O; Cavoretto P; Peralta CF; Csapo B; Nicolaides KH
    Ultrasound Obstet Gynecol; 2005 Dec; 26(7):755-60. PubMed ID: 16163740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for trisomies by cell-free DNA testing of maternal blood: consequences of a failed result.
    Revello R; Sarno L; Ispas A; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Jun; 47(6):698-704. PubMed ID: 26743020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of fetal nasal bone and aneuploidies at first-trimester nuchal translucency screening in unselected pregnancies.
    Zoppi MA; Ibba RM; Axiana C; Floris M; Manca F; Monni G
    Prenat Diagn; 2003 Jun; 23(6):496-500. PubMed ID: 12813765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First trimester ultrasound screening for Down syndrome based on maternal age, fetal nuchal translucency and different combinations of the additional markers nasal bone, tricuspid and ductus venosus flow.
    Abele H; Wagner P; Sonek J; Hoopmann M; Brucker S; Artunc-Ulkumen B; Kagan KO
    Prenat Diagn; 2015 Dec; 35(12):1182-6. PubMed ID: 26223508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity of multiple first trimester sonomarkers in fetal aneuploidy detection.
    Chanprapaph P; Dulyakasem C; Phattanchindakun B
    J Perinat Med; 2015 May; 43(3):359-65. PubMed ID: 25222592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First-trimester screening for trisomies 21, 18 and 13 by ultrasound and biochemical testing.
    Wright D; Syngelaki A; Bradbury I; Akolekar R; Nicolaides KH
    Fetal Diagn Ther; 2014; 35(2):118-26. PubMed ID: 24356462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.